CheckMyRecalls

Viatris, Inc. recalls Telmisartan and Amlodipine

Published
28 Oct 2026
Units affected
21,620 30-count bottles
Agency
FDA
Country
United States

The hazard

Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Telmisartan and Amlodipine, Tablets, USP, 40mg/5 mg, 30-count Bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 USA, Made in India, NDC 0378-1075-93.

Brand / company
Viatris, Inc.
Codes / lots
Lot # 3228113, 3228114, 3228115, Exp Date: Oct 31, 2026; Lot # 3228120, 3228121, Exp Date: Nov 30, 2026.
Distribution
Nationwide in the USA.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 28 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.